Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target
Lepak, A J, Reda, A, Marchillo, K, Van Hecker, J, Craig, W A, Andes, D
Published in Antimicrobial agents and chemotherapy (01.10.2014)
Published in Antimicrobial agents and chemotherapy (01.10.2014)
Get full text
Journal Article
In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus
Lepak, A J, Seiler, P, Surivet, J P, Ritz, D, Kohl, C, Andes, D R
Published in Antimicrobial agents and chemotherapy (01.06.2016)
Published in Antimicrobial agents and chemotherapy (01.06.2016)
Get full text
Journal Article
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches
Lepak, A J, Trang, M, Hammel, J P, Sader, H S, Bhavnani, S M, VanScoy, B D, Pogue, J M, Ambrose, P G, Andes, D R
Published in Antimicrobial agents and chemotherapy (18.04.2023)
Published in Antimicrobial agents and chemotherapy (18.04.2023)
Get full text
Journal Article
Antifungal pharmacokinetics and pharmacodynamics
Lepak, Alexander J, Andes, David R
Published in Cold Spring Harbor perspectives in medicine (01.05.2015)
Published in Cold Spring Harbor perspectives in medicine (01.05.2015)
Get full text
Journal Article